Clinical Trial Update: A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 study of paliperidone palmitate in Japanese patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED